TRABD2B

Across TCGA pan-cancer cohorts, TRABD2B RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated TRABD2B data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher TRABD2B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRABD2B expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

UVM, OV, and ESCA are the cancer types where TRABD2B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	All	0.410	0.801	<.001	127	view →
OV	OS	Tertile	All	0.622	0.759	.002	50	view →
ESCA	OS	Tertile	III,IV	0.769	0.298	.001	40	view →
BRCA	OS	Quartile	III,IV	0.921	0.766	.005	37	view →
MESO	DFS	Median	All	0.286	0.444	.003	34	view →
KIRC	DFS	Median	All	0.714	0.545	<.001	30	view →
ACC	DFS	Median	II,III,IV	0.383	0.759	.001	30	view →
HNSC	DFS	Quartile	All	0.484	0.790	<.001	29	view →
LUSC	DFS	Median	All	0.304	0.456	.002	25	view →
STAD	DFS	Median	IV	0.155	0.565	.009	25	view →
SKCM	OS	Median	IV	0.867	0.225	.001	24	view →
UCEC	OS	Quartile	III,IV	0.752	0.914	.006	22	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

TRABD2B–UVM (OS)

Open the UVM breakdown →